Tags

Type your tag names separated by a space and hit enter

Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season.
Vaccine 2011; 29(40):7075-9V

Abstract

For a number of years now, GEIG, the Groupement d'Expertise et d'Information sur la Grippe (Influenza Expertise and Information Group) has conducted surveys to monitor seasonal trivalent vaccine uptake in France in adults. During the H1N1 pandemic in 2009, this survey was conducted to determine vaccination uptake for both pandemic and seasonal vaccines. An additional specific questionnaire was used to collect data on vaccination in children under 15 years of age. This additional study was carried out because pandemic vaccination (PV) was offered to the French population and children were listed as a priority target group by the national health authorities, whereas seasonal trivalent inactivated vaccines (TIV) are not recommended in children in France. Overall, we collected 2443 questionnaires on children, including children with underlying conditions (9.2%) for whom TIV vaccination was recommended. Overall, 17.9% of children (438/2443) received at least one shot of PV, compared to 3.4% (83/2443) who received at least one shot of TIV. PV uptake was statistically different between non at-risk and at-risk children (366/2218 [16.5%] vs. 71/225 [31.8%], p<0.0001). This difference was even more significant in the subgroup of children with severe underlying diseases (42.7%, p<0.0001). This confirms that despite the low overall PV uptake in the French population (9%), the specific recommendation for PV for children increased vaccine uptake in this specific population, suggesting that the disease burden of influenza in children is recognised by both practitioners and parents. The next few years will tell us whether TIV uptake in children increases as a consequence of the specific recommendations made for children during the 2009 pandemic wave, or whether it will return to the very low level of 3.4% observed before the pandemic.

Authors+Show Affiliations

Université Paris 7 Diderot, Paris, France.No affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

21777639

Citation

Weil-Olivier, Catherine, and Bruno Lina. "Vaccination Coverage With Seasonal and Pandemic Influenza Vaccines in Children in France, 2009-2010 Season." Vaccine, vol. 29, no. 40, 2011, pp. 7075-9.
Weil-Olivier C, Lina B. Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season. Vaccine. 2011;29(40):7075-9.
Weil-Olivier, C., & Lina, B. (2011). Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season. Vaccine, 29(40), pp. 7075-9. doi:10.1016/j.vaccine.2011.07.018.
Weil-Olivier C, Lina B. Vaccination Coverage With Seasonal and Pandemic Influenza Vaccines in Children in France, 2009-2010 Season. Vaccine. 2011 Sep 16;29(40):7075-9. PubMed PMID: 21777639.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season. AU - Weil-Olivier,Catherine, AU - Lina,Bruno, Y1 - 2011/07/21/ PY - 2011/02/02/received PY - 2011/07/04/revised PY - 2011/07/06/accepted PY - 2011/7/23/entrez PY - 2011/7/23/pubmed PY - 2012/3/8/medline SP - 7075 EP - 9 JF - Vaccine JO - Vaccine VL - 29 IS - 40 N2 - For a number of years now, GEIG, the Groupement d'Expertise et d'Information sur la Grippe (Influenza Expertise and Information Group) has conducted surveys to monitor seasonal trivalent vaccine uptake in France in adults. During the H1N1 pandemic in 2009, this survey was conducted to determine vaccination uptake for both pandemic and seasonal vaccines. An additional specific questionnaire was used to collect data on vaccination in children under 15 years of age. This additional study was carried out because pandemic vaccination (PV) was offered to the French population and children were listed as a priority target group by the national health authorities, whereas seasonal trivalent inactivated vaccines (TIV) are not recommended in children in France. Overall, we collected 2443 questionnaires on children, including children with underlying conditions (9.2%) for whom TIV vaccination was recommended. Overall, 17.9% of children (438/2443) received at least one shot of PV, compared to 3.4% (83/2443) who received at least one shot of TIV. PV uptake was statistically different between non at-risk and at-risk children (366/2218 [16.5%] vs. 71/225 [31.8%], p<0.0001). This difference was even more significant in the subgroup of children with severe underlying diseases (42.7%, p<0.0001). This confirms that despite the low overall PV uptake in the French population (9%), the specific recommendation for PV for children increased vaccine uptake in this specific population, suggesting that the disease burden of influenza in children is recognised by both practitioners and parents. The next few years will tell us whether TIV uptake in children increases as a consequence of the specific recommendations made for children during the 2009 pandemic wave, or whether it will return to the very low level of 3.4% observed before the pandemic. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/21777639/Vaccination_coverage_with_seasonal_and_pandemic_influenza_vaccines_in_children_in_France_2009_2010_season_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(11)01039-5 DB - PRIME DP - Unbound Medicine ER -